These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19620605)

  • 1. IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders.
    Fillit H; Hess G; Hill J; Bonnet P; Toso C
    Neurology; 2009 Jul; 73(3):180-5. PubMed ID: 19620605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.
    Blumentals WA; Schulman KL
    Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
    Relkin NR; Szabo P; Adamiak B; Burgut T; Monthe C; Lent RW; Younkin S; Younkin L; Schiff R; Weksler ME
    Neurobiol Aging; 2009 Nov; 30(11):1728-36. PubMed ID: 18294736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis.
    Fu AZ; Christensen DB; Hansen RA; Liu GG
    Clin Ther; 2006 Jun; 28(6):979-89. PubMed ID: 16860180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the development of pedal edema in patients using pramipexole.
    Kleiner-Fisman G; Fisman DN
    Arch Neurol; 2007 Jun; 64(6):820-4. PubMed ID: 17420306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status epilepticus after stroke is associated with increased long-term case fatality.
    Knake S; Rochon J; Fleischer S; Katsarou N; Back T; Vescovi M; Oertel WH; Reis J; Hamer HM; Rosenow F
    Epilepsia; 2006 Dec; 47(12):2020-6. PubMed ID: 17201698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of familial aggregation of Parkinson disease and Alzheimer disease.
    Levy G; Louis ED; Mejia-Santana H; Côté L; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Ottman R; Marder K
    Arch Neurol; 2004 Jul; 61(7):1033-9. PubMed ID: 15262733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.
    Tandon P; Goodman KJ; Ma MM; Wong WW; Mason AL; Meeberg G; Bergsten D; Carbonneau M; Bain VG
    Am J Gastroenterol; 2009 Jul; 104(7):1700-6. PubMed ID: 19471253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer disease and risk of stroke: a population-based cohort study.
    Chi NF; Chien LN; Ku HL; Hu CJ; Chiou HY
    Neurology; 2013 Feb; 80(8):705-11. PubMed ID: 23303851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of comorbidity on costs for patients with Alzheimer disease.
    Kuo TC; Zhao Y; Weir S; Kramer MS; Ash AS
    Med Care; 2008 Aug; 46(8):839-46. PubMed ID: 18665064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
    Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
    Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke and the risk of Alzheimer disease.
    Honig LS; Tang MX; Albert S; Costa R; Luchsinger J; Manly J; Stern Y; Mayeux R
    Arch Neurol; 2003 Dec; 60(12):1707-12. PubMed ID: 14676044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
    Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
    Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA vasculitis in the elderly.
    Hoganson DD; From AM; Michet CJ
    J Clin Rheumatol; 2008 Apr; 14(2):78-81. PubMed ID: 18391675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after epilepsy surgery compared with matched epilepsy controls and the general population.
    Stavem K; Guldvog B
    Epilepsy Res; 2005 Jan; 63(1):67-75. PubMed ID: 15716033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset dementia is associated with higher mortality.
    Koedam EL; Pijnenburg YA; Deeg DJ; Baak MM; van der Vlies AE; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2008; 26(2):147-52. PubMed ID: 18679029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000.
    Pendergrast JM; Sher GD; Callum JL
    Vox Sang; 2005 Oct; 89(3):150-60. PubMed ID: 16146507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.